Is there an epigenetic component underlying the resistance of triple-negative breast cancers to PARP inhibitors? by Amanda eLovato, Lawrence ePanasci, Michael eWitcher

Get full text

Small molecules, inhibitors of DNA-PK, targeting DNA repair and beyond by David eDavidson, Lilian eAmrein, Lawrence ePanasci, Raquel eAloyz

Get full text

Systemic Cancer Therapy: by Michael Ostario Palumbo, Petr eKavan, Wilson eMiller, Lawrence ePanasci, Sarit eAssouline, Nathalie eJohnson, Victor eCohen, Francois ePatenaude, Michael ePollak, R Thomas Jagoe, Gerald eBatist

Get full text

Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan by Atlal eAbu-Sanad, Yunzhe eWang, Fatemeh eHasheminasab, Justin ePanasci, Alycia eNoe, Lorena eRosca, David eDavidson, Bahram eSharif-Askari, Lilian eAmrein, Raquel eAloyz, Lawrence ePanasci

Get full text